Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 40
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Artículo en Ruso | MEDLINE | ID: mdl-28884736

RESUMEN

The incidence of chronic endometritis remains rather high despite considerable progress in reproductive medicine including the advent of the new methods for assisted reproduction; the pregnancy rate after the treatment of this condition is still unacceptably low. It implies the necessity of the careful preparation of endometrium for the implantation of the embryo especially in women with a history of unsuccessful outcomes of the IVF treatment. It calls for the development of the efficient therapeutic modalities for the management of chronic endometritis and restoration of the normal reproductive function; their introduction into the therapeutic algorithm remains equally relevant. The characteristic features of chronic endometritis include blood circulatory disorders in the vessels of the uterus and in the pelvic vascular basin, changes of local immunity in the endometrium concomitant with the activation of cellular and humoral responses of inflammation in the form of enhanced leukocyte infiltration and increased production of cytokines. The long duration of such a process results in the development of fibrosis that, in its turn, leads to chronic tissue hypoxia, potentiation of inflammation, and disruption of decidualization that hampers successful implantation. The article shows the possibility of using low-intensity ultrasound for the treatment and rehabilitation of the patients presenting with chronic endometritis. The data concerning the primary biophysical processes developing in the tissues under the influence of ultrasound are discussed. The therapeutic effects and their underlying mechanisms and described. The physiotherapeutic treatment considerably improved vascular hemodynamics in the pelvic basin and produced trophotropic, defibrosing, and anti-inflammatory effects. The clinical data giving evidence of the high effectiveness of the application of intrauterine ultrasound cavitation provide a basis for the recommendation to include this physical factor in the existing algorithms for the pre-gravid preparation of the women presenting with disorders of the reproductive function and chronic endometritis.


Asunto(s)
Endometriosis/terapia , Terapia por Ultrasonido/métodos , Enfermedad Crónica , Endometriosis/rehabilitación , Endometrio/irrigación sanguínea , Endometrio/efectos de los fármacos , Endometrio/efectos de la radiación , Femenino , Humanos , Microcirculación/efectos de los fármacos , Microcirculación/efectos de la radiación , Fonoforesis , Polirribonucleótidos/administración & dosificación , Polirribonucleótidos/uso terapéutico , Resultado del Tratamiento , Ondas Ultrasónicas
2.
Vestn Oftalmol ; 126(5): 3-8, 2010.
Artículo en Ruso | MEDLINE | ID: mdl-21328882

RESUMEN

Recurrent corneal erosion (CE) is a common anterior eye disease, which usually occurs after injury, substantially limits a patient's ability to work, and is intractable. The authors single out an individual form of CE herpetic CE (HCE) on the basis of immunofluorescence assay of a conjunctival scrape, which shows the high concentration of herpes simplex virus antigen in 53% of CE cases. Confocal microscopy revealed epithelocyte polymorphism and basement membrane defects. The treatment of patients with HCE involved 2 steps: 1) relief of acute signs of the disease via drug therapy, rapid local autocyte cinotherapy (RLACCT), or phototherapeutic keratectomy (PTK) and 2) prevention of recurrences. For this the authors developed a method based on the systemic use of a new composition of the intradermal herpes vaccine Vitaherpavac in combination with the subcutaneous interferon inducer Poludan. RLACCT was found to be the most effective medical treatment for CE and PTK was the most effective surgical one. Vaccination with the concurrent subcutaneous injection of Poludan is an effective method in preventing recurrent HCE. During a follow-up of 2 years or more, 81% of the patients achieved clinical resolution; there was a decrease in recurrence rates and severity in 15.1% and no effect in 3.8%.


Asunto(s)
Úlcera de la Córnea/virología , Infecciones Virales del Ojo/virología , Queratitis Herpética/complicaciones , Adulto , Antivirales/uso terapéutico , Cirugía Laser de Córnea/métodos , Úlcera de la Córnea/diagnóstico , Úlcera de la Córnea/terapia , Infecciones Virales del Ojo/diagnóstico , Infecciones Virales del Ojo/terapia , Femenino , Estudios de Seguimiento , Humanos , Queratitis Herpética/diagnóstico , Queratitis Herpética/terapia , Masculino , Microscopía Confocal , Persona de Mediana Edad , Polirribonucleótidos/uso terapéutico , Recurrencia , Estudios Retrospectivos , Adulto Joven
3.
Antiviral Res ; 1(4): 237-48, 1981 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-6280608

RESUMEN

Administration of a single-stranded polynucleotide copolymer containing 9% cytidine residues and 91% 4-thiouridine residues [poly(C,S4U10)], a known potent inhibitor of the virion transcriptase of influenza viruses, suppressed the amount of virus recoverable from the nasal washes of influenza virus-infected hamsters and ferrets. The incidence of sneezing and nasal discharge in infected ferrets was also reduced. In hamsters, poly(C,S4U10) was more effective than amantadine-HCl or Virazole. Polyinosinic acid in combination with poly-5-hydroxy cytidylic acid also had anti-influenza effects. Poly(C,S4U10) annealed to polyadenylic acid was not effective, nor was the double-stranded polymer (polyinosinic acid) . (polycytidylic acid) even when complexed with carboxymethylcellulose and polylysine. No toxic effects of poly(C,S4U10) were apparent in the treated hamsters and ferrets, and high doses (greater than or equal to 2.86 g/kg) administered intraperitoneally to mice produced no adverse effects.


Asunto(s)
Antivirales/uso terapéutico , Virus de la Influenza A/efectos de los fármacos , Infecciones por Orthomyxoviridae/tratamiento farmacológico , Poli C/uso terapéutico , Poli U/uso terapéutico , Polirribonucleótidos/uso terapéutico , Animales , Cricetinae , ARN Polimerasas Dirigidas por ADN/antagonistas & inhibidores , Evaluación Preclínica de Medicamentos , Hurones , Virus de la Influenza A/enzimología , Masculino , Mesocricetus , Poli C/análogos & derivados , Poli I/uso terapéutico , Poli I-C/uso terapéutico
4.
J Refract Surg ; 15(2 Suppl): S234-7, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10202730

RESUMEN

BACKGROUND: Re-epithelialization is usually complete in eyes 3 to 4 days following photorefractive keratectomy (PRK). However, this process is delayed in 0.5% of these eyes, leading to early development of haze. The authors investigated a method to stimulate re-epithelialization following PRK. METHODS: PRK was performed with the Nidek EC-5000 excimer laser. Following surgery, express-cytokinotherapy was applied. This method consisted of a single subconjunctival injection of 2.5 to 3.0 ml of ex juvanticus mixture of autoblood and immunomodulator Poludan. This mixture was then applied topically 4 times a day until re-epithelialization was complete. Poludan is an interferon inducer (complex polyA: polyU), stimulates expressed production of interferon and interleukin-2, and increases natural cytotoxicity. RESULTS: Thirty eyes of 30 patients with delayed re-epithelialization were treated with the described method. The average time to re-epithelialization was 7.00 + 0.64 days. Total epithelialization was complete on day 3 + 0.38 after beginning the cytokinotherapy (P < .05). Early haze developed in only 2 patients from this group. Occurrence of early haze in the control group of patients who had persistent epithelial defects 8 to 16 days postoperatively and were given traditional therapy--including corticosteroid and non-steroidal drugs--was reliably higher: 8 to 10 days (P < .01). CONCLUSION: Local express-cytokinotherapy appears to be an effective method to promote quick and complete epithelialization in eyes following PRK that experience delayed re-epithelialization. This treatment may be an important part of the prevention of early haze development and achievement of better visual acuity.


Asunto(s)
Sangre , Epitelio Corneal/efectos de los fármacos , Inductores de Interferón/uso terapéutico , Queratectomía Fotorrefractiva , Polirribonucleótidos/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Adulto , Células Epiteliales/fisiología , Estudios de Seguimiento , Humanos , Hiperopía/cirugía , Láseres de Excímeros , Persona de Mediana Edad , Miopía/cirugía , Reproducibilidad de los Resultados , Resultado del Tratamiento , Agudeza Visual
5.
Am J Clin Oncol ; 10(4): 281-4, 1987 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-3039828

RESUMEN

Nine astrocytoma specimens were received from seven patients and processed for testing in the human tumor clonogenic assay (HTCA). Cells derived from these specimens were challenged with human natural alpha-interferon (alpha-IFN) and beta interferon (beta-IFN), recombinant beta interferon (beta ser-IFN), and mismatched double-stranded (ds) RNA (Ampligen). Six of the astrocytoma specimens formed adequate colonies for drug sensitivity testing (greater than or equal to 30 colonies/plate), and all were high-grade (III-IV) tumors. Sensitivity was defined as a greater than or equal to 50% decrease in tumor colony formation following drug exposure and was observed with alpha-IFN (2/4), beta-IFN (3/4), and mismatched dsRNA (4/5) exposure. No decrease in colony growth was observed after recombinant beta ser-IFN exposure, and in 2 of 3 cases, colony formation was stimulated. The sensitivity of 75 non-CNS solid tumors to mismatched dsRNA was compared to the high-grade astrocytomas in the HTCA. Of the 10 additional histologic tumor types studied, carcinoid and renal cell carcinomas exhibited the greatest sensitivity to mismatched dsRNA: 63% and 52%, respectively. However, in comparison, 80% of the high-grade astrocytomas were sensitive, demonstrating that these gliomas are among the most sensitive of human tumors to mismatched dsRNA in vitro. Clinical trials of interferons and mismatched dsRNA, coupled with in vitro sensitivity studies, should further define their therapeutic potential.


Asunto(s)
Astrocitoma , Neoplasias Encefálicas , Ensayo de Unidades Formadoras de Colonias , Interferón Tipo I/uso terapéutico , Interferón beta , Poli I-C , Poli U , Polirribonucleótidos/uso terapéutico , Proteínas Recombinantes/uso terapéutico , Ensayo de Tumor de Célula Madre , Astrocitoma/tratamiento farmacológico , Astrocitoma/patología , Neoplasias Encefálicas/tratamiento farmacológico , Neoplasias Encefálicas/patología , Carmustina/uso terapéutico , Línea Celular , Relación Dosis-Respuesta a Droga , Glioblastoma/tratamiento farmacológico , Glioblastoma/patología , Humanos , Interferón beta-1a , Interferon beta-1b
6.
Acta Virol ; 23(6): 481-8, 1979 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-94768

RESUMEN

The administration of sonicated fractions of f2 phage polyribonucleotides caused an increased weight loss and deterioration of the clinical state in female NZB mice. Discontinuance of the treatment resulted in an improvement of both the clinical state and the genetically determined autoimmune disorders of these mice. Some potential explanations of this effect are discussed.


Asunto(s)
Enfermedades Autoinmunes/tratamiento farmacológico , Polirribonucleótidos/uso terapéutico , Animales , Anticuerpos/análisis , Enfermedades Autoinmunes/inmunología , Enfermedades Autoinmunes/metabolismo , Complemento C3/análisis , ADN/inmunología , Femenino , Interferones/biosíntesis , Masculino , Ratones , Ratones Endogámicos NZB , Peso Molecular , Poli I-C/uso terapéutico , ARN Bicatenario/inmunología , ARN Bicatenario/uso terapéutico , Sonicación
7.
Vestn Ross Akad Med Nauk ; (2): 44-9, 2003.
Artículo en Ruso | MEDLINE | ID: mdl-12698890

RESUMEN

The author report about study results conducted in Russia during the recent 30 years and dedicated to the treatment of ocular pathologies caused by the virus of herpes simplex. Three high-efficiency directions took shape during the mentioned period: 1. Non-specific antiviral therapy based on the local and systemic administration of interferon inductors (poludan--complexes of poly A, poly U etc.) possessing an extensive spectrum of the antiviral and immune-modeling actions; 2. Antirecurrent therapy, including the application of herpetic vaccine against the virus of herpes simplex, types I and II, combined with immune-modeling agents. A focal allergic test with herpetic vaccine was offered, it made it possible, for the first time, a non-invasive diagnostics of intraocular herpes. 3. A system of sparing microsurgical methods adapted to the treatment of an active herpetic keratitis and its outcomes. A synergistic effect of interferon inductors and acyclovir was proven both experimentally and clinically; a method of local autocytokinotherapy (based on poludan), which turned out to be most effective in the treatment of severe lesions at the cornea and of intraocular herpes, was worked out. The authors believe that the methods and means offered for the treatment of ophthalmoherpes contribute, to a great extent, to handling with the ocular herpes viral infection.


Asunto(s)
Aciclovir/uso terapéutico , Antivirales/uso terapéutico , Herpes Zóster Oftálmico/tratamiento farmacológico , Vacunas contra Herpesvirus/administración & dosificación , Polirribonucleótidos/uso terapéutico , Aciclovir/administración & dosificación , Adulto , Ojo , Humanos , Inyecciones Subcutáneas , Masculino , Persona de Mediana Edad , Pomadas , Soluciones Oftálmicas , Polirribonucleótidos/administración & dosificación
8.
Vopr Virusol ; 29(3): 334-7, 1984.
Artículo en Ruso | MEDLINE | ID: mdl-6464427

RESUMEN

A model of tick-borne encephalitis in BALB/c mice was used to investigate the protective anti-viral effect of an interferon inducer, poly(G).poly(C), and specific gamma-globulin administered to the animals together or separately in small doses 24 hours before or after virus inoculation. Administration to the animals of poly(G).poly(C) alone or gamma-globulin alone was shown to produce a poor protective effect. Simultaneous administration of both preparations resulted in a significant decrease of mouse mortality after infection. As a result of the pretreatment of chick embryo cell cultures with poly(G).poly(C) before inoculation and the addition of specific immune serum to the agar overlay after the Sindbis virus inoculation, its multiplication was inhibited much more than after treatment of the cells with interferon inducer alone or antibody alone. Possible mechanisms of the observed additive antiviral effects of the interferon inducer and antibody, including those associated with the influence on the virus-induced interferon production, as well as the possibility of their combined use for the prevention and treatment of viral infections are discussed.


Asunto(s)
Anticuerpos Antivirales/inmunología , Especificidad de Anticuerpos , Antivirales/uso terapéutico , Encefalitis Transmitida por Garrapatas/terapia , Inductores de Interferón/uso terapéutico , Polirribonucleótidos/uso terapéutico , Animales , Evaluación Preclínica de Medicamentos , Encefalitis Transmitida por Garrapatas/inmunología , Inmunización Pasiva , Ratones , Ratones Endogámicos BALB C , Poli C/uso terapéutico , Poli G/uso terapéutico
10.
Vopr Virusol ; (4): 423-8, 1981.
Artículo en Ruso | MEDLINE | ID: mdl-6171099

RESUMEN

A comparative study of the interferon-inducing and anti-influenza activity of polyguacyl, an interferon inducer, given to human volunteers intranasally and as an aerosol, was carried out. The induction of endogenous interferon in the blood to 100-127 units/ml was observed only after intranasal administration of 5 mg polyguacyl. By both routes of administration the inducer did not diminish the implantation of the virus and development of postvaccination reactions in volunteers to intranasal administration of live influenza A (H1N1) vaccine.


Asunto(s)
Gripe Humana/tratamiento farmacológico , Inductores de Interferón/uso terapéutico , Poli C/uso terapéutico , Poli G/uso terapéutico , Polirribonucleótidos/uso terapéutico , Administración Intranasal , Adulto , Aerosoles , Evaluación de Medicamentos , Humanos , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/inmunología , Inductores de Interferón/administración & dosificación , Interferones/sangre , Persona de Mediana Edad , Placebos , Poli C/administración & dosificación , Poli G/administración & dosificación , Factores de Tiempo
11.
Vopr Virusol ; 30(3): 337-40, 1985.
Artículo en Ruso | MEDLINE | ID: mdl-2996241

RESUMEN

On the basis of synthesis of a series of poly(G, A).poly(C) copolymers with changing G:A ratio from 15:1 to 90:1 and trials of their biological activity in comparison with poly(G).poly(C), the size of poly(G) in it was evaluated within the range of a continuous double-stranded area necessary for the activity. The antiviral activity close to that of poly(G).poly(C) in experimental tick-borne encephalitis of mice and vesicular stomatitis virus infection of chick embryo cells was found only in poly(G,A).poly(C) complexes with a G:A ratio equal to or higher than 90:1. Consequently, the high activity of poly(G).poly(C) is present at an average length of poly(G) equal to 90-100 nucleotides within the limits of the continuous double-stranded area.


Asunto(s)
Poli C/uso terapéutico , Poli G/uso terapéutico , Polirribonucleótidos/uso terapéutico , Animales , Secuencia de Bases , Embrión de Pollo , Evaluación Preclínica de Medicamentos , Encefalitis Transmitida por Garrapatas/tratamiento farmacológico , Ratones , Ratones Endogámicos BALB C , Peso Molecular , Poli C/análisis , Poli G/análisis , Polirribonucleótidos/análisis , Relación Estructura-Actividad , Virus de la Estomatitis Vesicular Indiana/efectos de los fármacos , Ensayo de Placa Viral
12.
Antibiot Khimioter ; 45(6): 13-6, 2000.
Artículo en Ruso | MEDLINE | ID: mdl-10904803

RESUMEN

The cycloferon efficacy was investigated in the treatment of experimental herpesvirus kerato-conjunctivitis in rabbits. The model was demonstrated to reflect the main aspects of herpesvirus eye lesions in humans. Cycloferon application similarly to that of known interferon inducer poludan has been shown to enhance processes of inflammation and subsequent regeneration of eye tissues as well as to decrease mortality of animals due to the generalization of infection.


Asunto(s)
Acridinas/uso terapéutico , Inductores de Interferón/uso terapéutico , Queratitis Herpética/tratamiento farmacológico , Animales , Evaluación Preclínica de Medicamentos , Iridociclitis/diagnóstico , Iridociclitis/tratamiento farmacológico , Iridociclitis/patología , Iridociclitis/virología , Queratitis Herpética/diagnóstico , Queratitis Herpética/patología , Queratitis Herpética/virología , Polirribonucleótidos/uso terapéutico , Conejos , Simplexvirus/aislamiento & purificación , Factores de Tiempo
13.
Vestn Oftalmol ; 120(4): 21-4, 2004.
Artículo en Ruso | MEDLINE | ID: mdl-15384842

RESUMEN

It was for the first time in the ophthalmologic practice that a possibility was demonstrated to ensure relatively high and stable functional results, in a significant number of patients with transplanted kidney (TK), related with different-type cataract extraction and with implantation of a variety of PMMA IOLs, i.e. model of B.A. Alexeev, "Storz" company models made from domestic and foreign-made PMMA and domestic-silicone models (P = 70). It was established that IOL implantation in patients with TK is possible in all cases provided the kidney transplant is compensated for and there are no foci of acute or chronic inflammation in the body. A minimal trauma caused by surgery and the suggested scheme of postoperative management (intramuscular injections of antibiotics and supplementary administration of solutions of poludan, naclof, catachrom and actovegin-gel made alongside with routine instillations) cuts the risk of infectious-and-inflammatory as well as of degenerative-and-dystrophic complications in patients with TK receiving the suppressor therapy. Clinical examinations denoted that the intraocular aphakia correction in patients with TK is a method of choice accelerating the medical and social rehabilitation in the discussed patients' category provided the therapeutic-and-diagnostic as well as preventive measures, as required by their status, are being taken.


Asunto(s)
Hemo/análogos & derivados , Trasplante de Riñón , Implantación de Lentes Intraoculares , Adulto , Factores de Edad , Anciano , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Antioxidantes/administración & dosificación , Antioxidantes/uso terapéutico , Extracción de Catarata , Quimioterapia Combinada , Hemo/administración & dosificación , Hemo/uso terapéutico , Humanos , Inyecciones Intramusculares , Inductores de Interferón/administración & dosificación , Inductores de Interferón/uso terapéutico , Persona de Mediana Edad , Polirribonucleótidos/administración & dosificación , Polirribonucleótidos/uso terapéutico , Cuidados Posoperatorios
14.
Vestn Oftalmol ; 114(5): 23-8, 1998.
Artículo en Ruso | MEDLINE | ID: mdl-9865180

RESUMEN

Analysis of case histories and clinical and direct immunofluorescent examinations of 72 patients enabled the authors to single out 3 forms of complicated adenovirus keratoconjunctivitis (AVKC): 1) acute grave; 2) with toxic allergic reaction to previous treatment; and 3) steroid-complicated. Recommendations on the treatment of these forms are offered. A common remedy is interferon inductor poludan and chigain obtained from human colostrum and containing secretory IgA. Poludan was administered by instillations (4-6 times a day) and periocular injections in a dose of 100 U every 1-2 days, 5-6 injections per course, chigain was administered by instillations (2-4 daily). This combined treatment was highly effective and well tolerated. Periocular injection of poludan ensured much more intensive local and even systemic interferon production than instillations alone. Mean terms of treating complicated AVKC were compatible with those in uncomplicated forms: 14.3 +/- 2.1 vs. 13.2 +/- 1.2 days, respectively. Signs of herpesvirus infection were detected in one-third of patients with steroid-complicated AVKC. For eliminating corneal opacities in AVKC patients, enzyme phonophoresis, phototherapeutic keratectomy, and (in grave cases) lamellar keratoplasty are recommended.


Asunto(s)
Infecciones por Adenovirus Humanos/diagnóstico , Inmunoterapia/métodos , Queratoconjuntivitis/diagnóstico , Enfermedad Aguda , Infecciones por Adenovirus Humanos/complicaciones , Infecciones por Adenovirus Humanos/terapia , Adolescente , Adulto , Anciano , Antivirales/uso terapéutico , Factores Biológicos/efectos adversos , Factores Biológicos/uso terapéutico , Niño , Combinación de Medicamentos , Evaluación de Medicamentos , Femenino , Humanos , Inmunoglobulina A Secretora/uso terapéutico , Inductores de Interferón/efectos adversos , Inductores de Interferón/uso terapéutico , Queratoconjuntivitis/complicaciones , Queratoconjuntivitis/terapia , Masculino , Polirribonucleótidos/efectos adversos , Polirribonucleótidos/uso terapéutico
15.
Vestn Oftalmol ; 120(1): 29-32, 2004.
Artículo en Ruso | MEDLINE | ID: mdl-15017775

RESUMEN

The method of local express-autocytocinetherapy (LEACCT) consists in using an experimentally tested autologous complex of cytokines (alpha- beta- gamma-interferons, interleukins 2.8, tumor necrosis factor gamma etc.), which is produced by joining the autoblood of patients with immune-modulator poludan (complex poly A:poly U). The external LEACCT and the intrachamber LEACCT are distinguished. The former presupposes the administration (subconjunctivally and in installations) of the autoblood-poludan mixture. This method is used in herpes- and adenovirus keratoconjunctivitis, slow re-epithelization after laser keratectomy and in eye burns (178 patients). The latter comprises, apart from the external LEACCT procedures, a 1-4-time introduction of the mentioned mixture into patient's anterior chamber. It was used in endothelial herpetic keratoiridocyclitis, initial bullous keratopathy, severe keratoconus and in injuries of the anterior lens capsule (117 patients). The clinical-study results (main group--295 patients) show that the designed method based on poludan has pronounced anti-inflammatory and regenerative effects in different viral and virus-free lesions of the eye tissues; it is simple and can be applied in clinical settings. An increased visual acuity ranging from 0.05 to 1.0 was registered in 85% of cases. The action of the complex of cytokines is as close as possible to the physiological mechanism, which provides for avoiding the side-effects and for applying the treatment scheme in situations when the administration of other drugs is limited or their efficiency is not sufficient.


Asunto(s)
Citocinas/uso terapéutico , Oftalmopatías/tratamiento farmacológico , Inductores de Interferón/uso terapéutico , Polirribonucleótidos/uso terapéutico , Infecciones por Adenoviridae/tratamiento farmacológico , Conjuntivitis Viral/tratamiento farmacológico , Citocinas/administración & dosificación , Quemaduras Oculares/tratamiento farmacológico , Infecciones del Ojo/tratamiento farmacológico , Lesiones Oculares/tratamiento farmacológico , Humanos , Inductores de Interferón/administración & dosificación , Queratitis Herpética/tratamiento farmacológico , Queratoconjuntivitis/tratamiento farmacológico , Queratocono/tratamiento farmacológico , Polirribonucleótidos/administración & dosificación , Agudeza Visual
16.
Voen Med Zh ; 323(1): 45-7, 93, 2002 Jan.
Artículo en Ruso | MEDLINE | ID: mdl-11881202

RESUMEN

The epidemiological effectiveness of interferon inductor "Poludanum" produced by "LENS Pharm" (Russia) for prevention of acute respiratory viral infections was tested. The drug was administered among the students of Military Medical Academy (101 students) according to scheme 1: in a nose, 3 drops in each nasal passage two times per week during 4 weeks, with 2 week interruption then the scheme was repeated. The scheme 2 included 3 drops in each nasal passage once a week during 10 weeks (95 students). The placebo group (96 students) received the distilled water. In the students receiving "Poludanum" according to scheme 1 the incidence of acute respiratory diseases (ARD) was significantly lower than in the control group (p = 0.058). The coefficient of effectiveness was 50%, i.e. the incidence has decreased in two times. The use of poludanum according to scheme 2 caused no decrease in ARD incidence.


Asunto(s)
Antivirales/uso terapéutico , Gripe Humana/prevención & control , Inductores de Interferón/uso terapéutico , Personal Militar , Polirribonucleótidos/uso terapéutico , Enfermedades Respiratorias/prevención & control , Enfermedad Aguda , Humanos , Gripe Humana/epidemiología , Enfermedades Respiratorias/epidemiología
20.
Biull Eksp Biol Med ; 97(4): 446-8, 1984 Apr.
Artículo en Ruso | MEDLINE | ID: mdl-6326886

RESUMEN

Interferon inducers, dsRNA and poly (G) X poly (C) ( polyguacyl ), injected into mice intraperitoneally induced interferon formation, the maximal activity being equal to 640-1280 U/ml. Antiviral effect of the inducers was studied upon intraperitoneal and intracerebral injections. Both polyguacyl and dsRNA exerted a marked antiviral action against infection induced by murine encephalomyocarditis virus. The most powerful effect was attained when the inducers were injected 24 or 4 h before challenge. The protective action was produced by polyguacyl and dsRNA even after intracerebral infection. There is a good agreement between the interferon-inducing and antiviral activity of interferon inducers. The data obtained demonstrate the fitness of experimental encephalomyocarditis of mice for testing interferon inducers.


Asunto(s)
Infecciones por Enterovirus/prevención & control , Inductores de Interferón/uso terapéutico , Poli C/uso terapéutico , Poli G/uso terapéutico , Polirribonucleótidos/uso terapéutico , ARN Bicatenario/uso terapéutico , Animales , Virus de la Encefalomiocarditis , Ratones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA